scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41577-020-0381-7 |
P698 | PubMed publication ID | 32764670 |
P50 | author | Irini Sereti | Q37383379 |
Asier Sáez-Cirión | Q37618043 | ||
P2860 | cites work | Immune activation and inflammation in HIV-1 infection: causes and consequences | Q22252860 |
Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages | Q24533266 | ||
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms | Q24534904 | ||
N-linked glycosylation and sequence changes in a critical negative control region of the ASCT1 and ASCT2 neutral amino acid transporters determine their retroviral receptor functions | Q24550685 | ||
Myristoylation-dependent replication and assembly of human immunodeficiency virus 1 | Q24559906 | ||
Targeting cellular metabolism to improve cancer therapeutics | Q24596727 | ||
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1 | Q24609814 | ||
SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells | Q24615124 | ||
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates | Q24624362 | ||
mTOR regulates memory CD8 T-cell differentiation | Q24648624 | ||
Fundamentals of cancer metabolism | Q26744062 | ||
Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis | Q26747110 | ||
Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection | Q27317216 | ||
Impaired Hepatitis C Virus (HCV)-Specific Effector CD8+ T Cells Undergo Massive Apoptosis in the Peripheral Blood during Acute HCV Infection and in the Liver during the Chronic Phase of Infection | Q27487035 | ||
HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase | Q27675416 | ||
Stealing the Keys to the Kitchen: Viral Manipulation of the Host Cell Metabolic Network | Q28084730 | ||
The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV | Q28184983 | ||
The end of AIDS: HIV infection as a chronic disease | Q28300749 | ||
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 | Q28307312 | ||
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance | Q29616026 | ||
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 | ||
Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef. | Q30379978 | ||
Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization | Q30912206 | ||
HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study | Q33361587 | ||
Enhancing CD8 T-cell memory by modulating fatty acid metabolism | Q33577204 | ||
Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals | Q33734957 | ||
Metabolic shifts in immunity and inflammation. | Q33829813 | ||
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism | Q33889154 | ||
HIV preferentially infects HIV-specific CD4+ T cells | Q33958893 | ||
Redefining chronic viral infection | Q34018497 | ||
Metabolic Response to Infection | Q34020619 | ||
Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1 | Q34085034 | ||
The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy | Q34106235 | ||
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies. | Q39178061 | ||
Metabolic Instruction of Immunity. | Q39286043 | ||
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion | Q39518055 | ||
Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis | Q39544233 | ||
Anatomical loci of HIV-associated immune activation and association with viraemia | Q39665842 | ||
Evidence for Altered Glutamine Metabolism in Human Immunodeficiency Virus Type 1 Infected Primary Human CD4+ T Cells. | Q40069186 | ||
HIV-1 selectively targets gut-homing CCR6+CD4+ T cells via mTOR-dependent mechanisms. | Q40097445 | ||
Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV. | Q40151022 | ||
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. | Q40343692 | ||
Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease. | Q40456141 | ||
Macrophage Polarization. | Q40463776 | ||
T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections | Q40572663 | ||
Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host. | Q40601767 | ||
Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr. | Q40651480 | ||
Glucose transporter 1-expressing proinflammatory monocytes are elevated in combination antiretroviral therapy-treated and untreated HIV+ subjects | Q41678934 | ||
Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infection | Q41857492 | ||
The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages | Q42272413 | ||
Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection | Q42514844 | ||
The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment | Q42593305 | ||
Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells. | Q45925404 | ||
AMPK: guardian of metabolism and mitochondrial homeostasis. | Q45982416 | ||
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation | Q46937571 | ||
Immune Responses to Retroviruses. | Q47554438 | ||
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health | Q47659177 | ||
M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. | Q47884316 | ||
Metabolic exhaustion in infection, cancer and autoimmunity. | Q48102749 | ||
Immunometabolism in 2017: Metabolism and the inflammasome in health and ageing | Q49501276 | ||
HIV latency is reversed by ACSS2-driven histone crotonylation | Q49851068 | ||
The spectrum of T cell metabolism in health and disease | Q49853005 | ||
The Human Microbiome and Obesity: Moving beyond Associations | Q50094859 | ||
Molecular signature of CD8+ T cell exhaustion during chronic viral infection. | Q51970485 | ||
Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. | Q51994120 | ||
Glutaminolysis activates Rag-mTORC1 signaling. | Q52301079 | ||
Unraveling the Complex Interplay Between T Cell Metabolism and Function. | Q52314225 | ||
Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1. | Q52727826 | ||
Protein Kinase C-β Dictates B Cell Fate by Regulating Mitochondrial Remodeling, Metabolic Reprogramming, and Heme Biosynthesis. | Q54976656 | ||
Metabolic pathway activation distinguish transcriptional signatures of CD8+ T cells from HIV-1 elite controllers | Q57023717 | ||
Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth | Q57160050 | ||
Fasting and cancer: molecular mechanisms and clinical application | Q57459389 | ||
Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction | Q57463606 | ||
IL-15 enhances survival and function of HIV-specific CD8+ T cells | Q58479905 | ||
Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding | Q34191382 | ||
Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation | Q34245351 | ||
Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase | Q34313399 | ||
HIV cure research: advances and prospects | Q34410446 | ||
Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection | Q34545726 | ||
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease | Q34555620 | ||
PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. | Q34583193 | ||
HIV-1 pathogenicity and virion production are dependent on the metabolic phenotype of activated CD4+ T cells | Q34617099 | ||
Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
Tissue-Resident Macrophage Ontogeny and Homeostasis | Q34676333 | ||
The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection | Q34734469 | ||
HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis | Q34848256 | ||
Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection | Q34943158 | ||
Mitochondria in HIV-1-induced apoptosis. | Q35120763 | ||
Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions | Q35168397 | ||
Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection | Q35208371 | ||
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation | Q35311785 | ||
Viral activation of cellular metabolism | Q35582251 | ||
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype | Q35749755 | ||
Glut1-mediated glucose transport regulates HIV infection | Q35787190 | ||
Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation | Q35848821 | ||
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice | Q35910232 | ||
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. | Q35918353 | ||
In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment | Q35928036 | ||
Omega 3 Fatty Acids Supplementation and Oxidative Stress in HIV-Seropositive Patients. A Clinical Trial | Q35970578 | ||
Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point | Q36074846 | ||
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. | Q36077348 | ||
Regulation and function of mTOR signalling in T cell fate decisions | Q36157753 | ||
Metabolic patterns in three types of phagocytizing cells | Q36185527 | ||
The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells | Q36199966 | ||
The mTOR Complex Controls HIV Latency | Q36225471 | ||
Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade | Q36227971 | ||
Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes | Q36342211 | ||
Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Human Immunodeficiency Virus-Associated Immune Reconstitution Inflammatory Syndrome | Q59352656 | ||
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection | Q59353468 | ||
Antiretroviral nucleoside and nucleotide analogues and mitochondria | Q61928346 | ||
How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication | Q64067571 | ||
Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection | Q64092550 | ||
Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway | Q64099960 | ||
Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol | Q64100143 | ||
HIV infection and latency induce a unique metabolic signature in human macrophages | Q64118463 | ||
The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages | Q64261973 | ||
Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma | Q64290756 | ||
Dynamics of T cell responses in HIV infection | Q77801088 | ||
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors | Q78342521 | ||
Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells | Q88866382 | ||
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection | Q89454256 | ||
Obesity and Weight Gain in Persons with HIV | Q89771713 | ||
Single-cell glycolytic activity regulates membrane tension and HIV-1 fusion | Q89831100 | ||
HIV-1 Envelope Overcomes NLRP3-Mediated Inhibition of F-Actin Polymerization for Viral Entry | Q90281589 | ||
Defining 'T cell exhaustion' | Q90391279 | ||
Seeing Is Believing: Nuclear Imaging of HIV Persistence | Q90401095 | ||
Precursor exhausted T cells: key to successful immunotherapy? | Q90576088 | ||
Cutting Edge: Elevated Glycolytic Metabolism Limits the Formation of Memory CD8+ T Cells in Early Life | Q90616271 | ||
TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision | Q90670638 | ||
Cellular Metabolism Is a Major Determinant of HIV-1 Reservoir Seeding in CD4+ T Cells and Offers an Opportunity to Tackle Infection | Q90727450 | ||
HIV controllers: to treat or not to treat? Is that the right question? | Q90779635 | ||
Translating In Vitro T Cell Metabolic Findings to In Vivo Tumor Models of Nutrient Competition | Q90836853 | ||
The Metabolic Profile of Tumor and Virally Infected Cells Shapes Their Microenvironment Counteracting T Cell Immunity | Q90860980 | ||
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer | Q91195832 | ||
Immunometabolism at the interface between macrophages and pathogens | Q91212060 | ||
High-fat diet exacerbates SIV pathogenesis and accelerates disease progression | Q91225018 | ||
Short Communication: Metformin Reduces CD4 T Cell Exhaustion in HIV-Infected Adults on Suppressive Antiretroviral Therapy | Q91300223 | ||
Invariant NKT Cells Functionally Link Microbiota-Induced Butyrate Production and Joint Inflammation | Q91302207 | ||
HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy | Q91341307 | ||
Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling | Q91626106 | ||
T cell metabolism in chronic viral infection | Q91639499 | ||
Immunometabolism and natural killer cell responses | Q91945216 | ||
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV | Q92145928 | ||
The Role of Macrophages in HIV-1 Persistence and Pathogenesis | Q92188718 | ||
CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo | Q92404277 | ||
Obesity and Fat Metabolism in Human Immunodeficiency Virus-Infected Individuals: Immunopathogenic Mechanisms and Clinical Implications | Q92504786 | ||
Specific Biological Features of Adipose Tissue, and Their Impact on HIV Persistence | Q92537912 | ||
Metabolic coordination of T cell quiescence and activation | Q92578624 | ||
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy | Q92637629 | ||
Effect of HIV infection and antiretroviral therapy on immune cellular functions | Q92884412 | ||
Modulation of asymmetric cell division as a mechanism to boost CD8+ T cell memory | Q93064881 | ||
Anti-apoptotic clone 11 derived peptides induce in vitro death of CD4+ T cells susceptible to HIV-1 infection | Q94461327 | ||
Entry of glucose- and glutamine-derived carbons into the citric acid cycle supports early steps of HIV-1 infection in CD4 T cells | Q94565400 | ||
Metabolic plasticity of HIV-specific CD8+ T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection | Q97643365 | ||
Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation | Q38973447 | ||
B-cell responses to HIV infection | Q39108710 | ||
Purinergic receptors are required for HIV-1 infection of primary human macrophages | Q36429974 | ||
Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production | Q36547664 | ||
Human immunodeficiency virus infection and macrophage cholesterol metabolism | Q36631236 | ||
Metabolic switching and fuel choice during T-cell differentiation and memory development | Q36820974 | ||
CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells | Q37058153 | ||
p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway | Q37240650 | ||
Intracellular nucleotide levels and the control of retroviral infections | Q37244704 | ||
What we talk about when we talk about fat. | Q37601812 | ||
Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection | Q37643812 | ||
HIV-1 persistence in CD4+ T cells with stem cell-like properties | Q37646541 | ||
Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states | Q37658834 | ||
Macrophage polarization and HIV-1 infection. | Q37665065 | ||
Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets | Q37682352 | ||
Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. | Q37688914 | ||
Oxygen Levels and Immunological Studies | Q37712473 | ||
mTOR, metabolism, and the regulation of T-cell differentiation and function | Q38034265 | ||
Restrictions to HIV-1 replication in resting CD4+ T lymphocytes | Q38111619 | ||
HIV controllers: a genetically determined or inducible phenotype? | Q38114915 | ||
FDG-PET imaging in HIV infection and tuberculosis. | Q38125724 | ||
The growing landscape of lysine acetylation links metabolism and cell signalling | Q38232935 | ||
Fatty acid metabolism in the regulation of T cell function | Q38320023 | ||
Targeting T cell metabolism for therapy | Q38324388 | ||
Regulation of mammalian nucleotide metabolism and biosynthesis | Q38335072 | ||
Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection. | Q38433251 | ||
Deoxyribonucleotide metabolism, mutagenesis and cancer | Q38572102 | ||
Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection | Q38749963 | ||
Immunometabolism: an emerging frontier | Q38876919 | ||
A guide to immunometabolism for immunologists. | Q38891307 | ||
Role of hexokinase-1 in the survival of HIV-1-infected macrophages | Q38918452 | ||
P577 | publication date | 2020-08-06 | |
P1433 | published in | Nature Reviews Immunology | Q43355 |
P1476 | title | Immunometabolism and HIV-1 pathogenesis: food for thought |
Search more.